Innate Pharma S.a.s., based in Marseille, France, is a biotechnology company focused on developing innovative immunotherapies for cancer treatment. The organization specializes in harnessing the immune system to target and eliminate cancer cells, with a strong emphasis on monoclonal antibodies and other immune-modulating therapies. Innate Pharma is dedicated to advancing its research in oncology, aiming to provide effective solutions for patients facing various types of cancer through cutting-edge scientific approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#11 in Marseille

#1,710 in France

#56,047 in the World

Marseille, France

Innate Pharma S.a.s.

Forward Citations = 88

26 inventors:

Peter Andreas Nicolai Reumert Wagtmann (8 out of 17 patents)

Alessandro Moretta (5 out of 21 patents)

Francois Romagne (5 out of 12 patents)

4. Anders Svensson (5 out of 10 patents)

5. Stefan Zahn (5 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Innate Pharma S.a.s.. Retrieved from https://idiyas.com/company/innate-pharma-s-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]